First-trimester diagnosis of Meckel-Gruber syndrome by fetal ultrasound with molecular identification of CC2D2A mutations by next-generation sequencing

被引:10
|
作者
Jones, D. [1 ]
Fiozzo, F. [1 ]
Waters, B. [2 ]
McKnight, D. [3 ]
Brown, S. [1 ]
机构
[1] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
[3] GeneDx Inc, Gaithersburg, MD USA
关键词
fetal malformation; gene mutation; Meckel-Gruber syndrome; next-generation sequencing;
D O I
10.1002/uog.13381
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
We describe a first-trimester ultrasound examination in which the finding of fetal encephalocele and the cystic appearance of the kidneys raised suspicion of Meckel-Gruber syndrome (MKS). On the basis of sonographic findings, the patient elected termination of pregnancy, and post-termination studies using next-generation sequencing of a gene panel revealed two mutations (one previously described and the other novel) in the gene CC2D2A. Mutations in CC2D2A are known to cause MKS and Joubert syndrome, thus providing molecular confirmation of the clinical suspicion of MKS and opening the possibility for future prenatal diagnosis. This case highlights the ability to detect important anomalies in the first trimester using ultrasound, even in low-risk situations. It also demonstrates the growing role of new sequencing technologies in fetal testing. Copyright (c) 2014 ISUOG. Published by John Wiley & Sons Ltd.
引用
收藏
页码:719 / 721
页数:3
相关论文
共 46 条
  • [41] Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
    Kohlmann, Alexander
    Grossmann, Vera
    Klein, Hans-Ulrich
    Schindela, Sonja
    Weiss, Tamara
    Kazak, Beray
    Dicker, Frank
    Schnittger, Susanne
    Dugas, Martin
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) : 3858 - 3865
  • [42] Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System
    Kinoshita, Moritoshi
    Higashihara, Eiji
    Kawano, Haruna
    Higashiyama, Ryo
    Koga, Daisuke
    Fukui, Takafumi
    Gondo, Nobuhisa
    Oka, Takehiko
    Kawahara, Kozo
    Rigo, Krisztina
    Hague, Tim
    Katsuragi, Kiyonori
    Sudo, Kimiyoshi
    Takeshi, Masahiko
    Horie, Shigeo
    Nutahara, Kikuo
    PLOS ONE, 2016, 11 (11):
  • [43] Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 75% of Chronic Myelomonocytic Leukemia (CMML) by Detecting Frequent Alterations in TET2, RUNX1, CBL, and RAS
    Kohlmann, Alexander
    Grossmann, Vera
    Haferlach, Claudia
    Kazak, Beray
    Schindela, Sonja
    Klein, Hans-Ulrich
    Weiss, Tamara
    Dicker, Frank
    Schnittger, Susanne
    Dugas, Martin
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2009, 114 (22) : 173 - 174
  • [44] The implication of 'unknown significance' variants in next-generation sequencing in diagnosis and donor selection for allogenic haematopoietic stem cell transplantation. Report of a case of myelodysplastic syndrome with a polymorphism in the tyrosine kinase 2 (TYK2) gene
    Lopez-Andrade, Bernardo
    Bento, Leyre
    Campelo, Maria
    Cadenas, Felix
    Martin, Teresa
    Lo Riso, Laura
    Novo, Andres
    Martinez-Serra, Jorge
    Ballester, Carmen
    Sampol, Antonia
    Duran, Maria Antonia
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : E180 - E182
  • [45] Identification of a SNP and development of a PCR-based allele-specific marker of the sporulation-deficient (sporeless) trait of the Tamogitake 108Y2D mutant using next-generation sequencing
    Yoneyama, Shozo
    Shirai, Nobuki
    Ando, Natsumi
    Azuma, Tomonori
    Tsuda, Mayumi
    Matsumoto, Teruyuki
    BREEDING SCIENCE, 2020, 70 (05) : 530 - 539
  • [46] Chronic myelomonocytic leukemia (CMML) is characterized by frequent alterations in TET2, RUNX1, CBL, and RAS: A next-generation deep-sequencing study reveals a characteristic pattern of molecular mutations in 72.8% of patients
    Kohlmann, A.
    Grossmann, V
    Klein, H-U
    Haferlach, C.
    Schnittger, S.
    Kern, W.
    Dugas, M.
    Haferlach, T.
    ONKOLOGIE, 2010, 33 : 227 - 227